Navigation Links
Anchor in Biological Technology

New rotors could help develop nanoscale generators

... The researchers used a gold metal surface to anchor phtalocyanine molecules, which have a metallic centre, in a large array. The anchor point, a single gold atom on top of the gold ... molecular rotors is that molecules need a fixed anchor point and will often react with the surface you ...

Alexandria Real Estate Equities, Inc. Signs Biopharmaceutical Company, Lilly, as Anchor New York City Tenant at the Alexandria Center for Science and Technology

... has entered into a long-term lease with Eli Lilly and Company as the anchor tenant at the Alexandria Center for Science and Technology at East River ... lab space they need to locate and expand. Lilly's decision to become its anchor tenant is evidence that our work is paying off. It also serves as a major ...

Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS

... failed to block the enzyme in a cellular assay, was coupled to a sterol anchor molecule and a potent inhibition of Beta-secretase activity demonstrated. ... where Beta-secretase cleaves APP. Evidence was also provided that the RAFT anchor could not be substituted by any other lipid type and that knowledge of ...

Video: New Way RA(TM) Talk Show Premieres Online for People Living With Rheumatoid Arthritis (RA)

... HORSHAM, Pa., July 29 /PRNewswire/ -- New Way RA (TM), a new online talk show hosted by award-winning journalist and anchor of Inside Edition, Deborah Norville, premieres today at www.NewWayRA.com . To view the Multimedia News Release, go to: ....

Muscular protein bond -- strongest yet found in nature

... these in turn hinge on the stability with which it is anchored in a structure called the sarcomeric Z-disk. Research published in 2006 showed this anchor to be a rare palindromic arrangement of proteins that is, it "reads" the same way forward and backward in which two titin molecules are connected ...

New Report Just Published: World Endoscopy Systems Market Report

... Hip Access Cannula II-39 Conmed Releases New Endoscopy Products II-39 Smith & Nephew Endoscopy Unleashes Bioraptor(TM) 2.3 PK Suture anchor II-40 Olympus Introduces Capsule Endoscope II-40 FDA Approves Video-Based Endoscopes by Vision-Sciences II-40 PENTAX Medical Launches ...

deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Service

... This variant does not confer sufficient risk to be of clinical utility on its own. But when measured in addition to our TCF7L2 variant that is the anchor of the deCODE T2(TM) test, it may, like other common variants conferring modest risk, enable the test to capture an even larger proportion of ...

Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

SulphCo Adds New Board Member

... He also served as Chairman of the Board of Unibar Corporation, the largest domestic independent drilling fluids company, until its sale in 1991 to anchor Drilling Fluids. He currently serves as Interim President for Nova Biosource Fuels, Inc. (Amex), a refiner and marketer of renewable biodiesel fuel ...

Stem cells stand up for themselves

... view is that the niche shapes stem cells, not vice versa. O'Reilly et al. found evidence for more active stem cells while studying how the cells anchor themselves in the Drosophila ovary. Previous work indicated that ovary stem cells attach to the niche through the protein E-cadherin. O'Reilly et ...

Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.

... of significant international opportunities. Our three year manufacturing contract with General Electric subsidiary Farmland Dairies will anchor the domestic growth of our Ready-to-Drink product in the immuno-compromised and Long Term Care and Sports Channels. At this point in the Company's ...

Genta Announces Second Quarter 2008 Financial Results and Conference Call

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

Genta Submits NDA Amendment to FDA for Genasense as Treatment of Chronic Lymphocytic Leukemia

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

Genta Announces Transfer of its Common Stock to the OTC Bulletin Board

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

Genta Announces Pending Transfer of its Common Stock to the Over-the-Counter Bulletin Board

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

Nanoengineered barrier invented to protect plastic electronics from water degradation

... IMREs breakthrough technology comes as Singapore seeks to jumpstart a plastic electronics industry locally as part of the countrys long-term plan to anchor new knowledge-intensive industries in the economy. The global plastic electronics industry is projected to grow to a market size of more than ...

Dell Pediatric Research Institute Receives $1 Million Gift from the Bank of America Charitable Foundation

... We applaud the university's efforts and are proud to take this opportunity to join them in the creation of the Institute, which will serve as an anchor in our community by driving economic growth, attracting leading experts and generating world- class research in the field of pediatric medicine." ...

EMD Serono Announces Planned Investment of $50 Million in Research Center in Massachusetts

... common goal of finding new treatments for unmet medical needs. "This announcement reflects Merck KGaA's strong commitment to expand EMD Serono and anchor our US operations in Massachusetts," said Elmar Schnee, Member of the Executive Board Merck KGaA and Head of Pharmaceuticals. "We recognize the ...

Science Fuels DNA Testing Controversy with Prejudicial Misquote

... ). The actual statement is: Paxil (paroxetine) is metabolized through CYP2D6. Pharmacogenetic testing of this pathway serves as an anchor for the intense personalization required to effectively prescribe Paxil and other antidepressant medicines. Facts and quotes: -- "The ...

Genta Restructures Operations to Focus on Priority Initiatives

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

Genta Granted Extension to Achieve Compliance with NASDAQ Listing Requirements

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

Auditors for Genta Incorporated Express Going Concern Qualification

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

Assembly technique for tiny wires may eventually help detect cancer and other diseases

... approach, placing a layer of a different photoresist on top of the chip and removing a small cube of photoresist around the tip where the wire anchor will be built. The researchers then electro-deposit metal into the tiny square holes, anchoring the nanowire in place. They dissolve the photoresist, ...

Genta Announces Senior Management Changes

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

Genta Announces Common Stock Offering of Approximately $3.1 Million

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

Genta Incorporated to Present at the BIO CEO & Investor Conference

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

Genta Receives Notice of Non-Compliance With NASDAQ Rule

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

Genta Receives NASDAQ Non-Compliance Notice

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

USGI Medical Demonstrates First System for Gastrotomy Closure in NOTES

... appendectomy, liver biopsy, and many others using NOTES techniques. Because of the versatility of the system, the EOS can also be used to create and anchor full thickness folds within the stomach, opening the door for Incisionless obesity-related procedures." The University of California at San Diego ...

Microfabrica Introduces Set of Miniature 'Building Blocks' for Minimally-Invasive Medical Devices

... ultrasound catheters, eliminating the need for a drive cable," noted Adam Cohen, chief technology officer of Microfabrica. "The expander can anchor and manipulate a catheter or retract tissue, while chainmail-based fabric is well- suited for distal protection or retrieval, especially in tortuous ...

Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium

... with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead ...

The Food Allergy & Anaphylaxis Network (FAAN) and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies

... groups, families and individually. Also attending will be national FAAN representatives who will be joined by Monica Dean, NBC 7/39 Reporter and anchor and San Diego FAAN walk Honorary Chair; Jeremy Dinkins, San Diego FAAN Walk Child Ambassador; and Kathleen Toohill, San Diego FAAN Walk Teen ...

Ciscos John Morgridge Speaks on How Wisconsin can Develop Successful Technology Clusters

... of having one or more major industries to anchor a cluster -- pointing to the crucial role that ... of Silicon Valley. "It is important to have an anchor property in each of your clusters," Morgridge ... companies and ideas. Make sure you involve the anchor firm or firms in your cluster." Wisconsin's ...

Creating thousands of jobs, Chicagos biotech space to triple

... concentration of universities. Three of them anchor the area: Harvard/Radcliffe, Boston University ... what makes a mall work is the presence of key anchor stores that will not only attract the multitude ... I emphasized that it will need some well-known anchor tenants and lots of specialty companies. My ...
Other Contents
(Date:5/28/2015)... 28, 2015 Industry analyst firm n-tech ... report titled "Markets for Self-Healing Materials: 2015-2022." According to ... and vascular systems, biomaterials, relevant shape memory materials ... $2.7 billion by 2020. The report ... of smart materials. Other recent n-tech reports have included ...
(Date:5/22/2015)... According to a new market ... Thermal, Emotion, Forensic), by Software (Middleware, Databases), by Hardware (Cameras, ... and Home) - Global Forecast to 2020", published by ... in 2015 to $6.19 Billion by 2020, at a ... data Tables and   43 Figures spread through 140 ...
(Date:5/19/2015)... Fingerprint Cards (FPC) has received an ... and FPC1035 from one if its module partners. Deliveries are ... 2015 and the sensors will be used by smartphone manufacturers ... 2015 hereby amount to 740 MSEK to date. In addition ... and a number of smaller orders not separately communicated amounting ...
Breaking Biology News(10 mins):The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 3Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2
(Date:5/29/2015)... NY (PRWEB) May 29, 2015 The ... as well as a number of specific concerns within, ... stigma reduction and mental health in the workplace. We ... mental health. The campaign also brings special focus to ... individuals to speak up and seek help from healthcare ...
(Date:5/29/2015)... Ca (PRWEB) May 29, 2015 ... pain consultations with specialists, physical therapy, and injections ... experiencing mid back and/or lower back pain, Healthpointe ... epidural injections for herniated discs, disc protrusions and ... . , Healthpointe’s team of renowned surgeons ...
(Date:5/29/2015)... 2015 The Global Allopurinol Industry ... on the current state of the Allopurinol industry.With ... statistics on the state of the industry and ... for companies and individuals interested in the market. ... industry including definitions, classifications, applications and industry chain ...
(Date:5/29/2015)... Florida (PRWEB) May 29, 2015 Designed ... Bodybuilding.com teamed up to create an all new, exclusive ... are a formulated with the latest and greatest, high ... and proven to be effective. The 24/7 Series can ... to cross-fitters and even the casual fitness enthusiasts. There ...
(Date:5/29/2015)... Javlin continues to fulfill its worldwide growth ... larger team, with the intention to better serve the ... the U.S. and Canada. , Javlin Inc., the wholly ... in 2014 with its strongest earnings to date, based ... CloverETL. To accelerate further progress and ensure exceptional customer ...
Breaking Medicine News(10 mins):Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3Health News:Allopurinol Industry (Global, China) 2015 Research Analysis and 2020 Forecasts 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:Growth of Data Integration Platform CloverETL Continues in North America 2
Other TagsOther Tags